What 5 Analyst Ratings Have To Say About CARISMA Therapeutics
Within the last quarter, CARISMA Therapeutics (NASDAQ:CARM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Carisma Announces Latest Data From Phase 1 Clinical Trial Of CT-0508 At 8th Annual CAR-TCR Summit
Group 2 data available to date support primary safety and feasibility endpoints of single-day bolus dosing of CT-0508
New translational analyses combining group 1 & group 2 continue to support CAR-M mechanism
Analyst Ratings for CARISMA Therapeutics
Within the last quarter, CARISMA Therapeutics (NASDAQ:CARM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.
Benzinga’s Top Ratings Upgrades, Downgrades For July 6, 2023
Upgrades According to RBC Capital, the prior rating for Repligen Corp (NASDAQ:RGEN) was changed from Sector Perform to…
Carisma Therapeutics Announces First Patient Dosed In Phase 1 Study of CT-0508 In Combination With KEYTRUDA In Patients With HER2 Overexpressing Solid Tumors
Study is designed to evaluate the potential for a synergistic effect of CAR-M therapy in combination with KEYTRUDA®
PHILADELPHIA, June 28, 2023 /PRNewswire/ -- Carisma Therapeutics
Steelcase, Commercial Metals And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session.
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for political campaigns.
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Avalo Therapeutics (NASDAQ:AVTX) shares rose 17.3% to $3.53 during Wednesday’s regular session. The company’s market cap stands…
Benzinga’s Top Ratings Upgrades, Downgrades For May 24, 2023
Upgrades According to RBC Capital, the prior rating for Northland Power Inc (OTC:NPIFF) was changed from Sector Perform…